BUILDING A NEXT-GEN PHARMA EXCIPIENTS PLATFORM
MCC, SSG, CCS, Crospovidone (PVPP), and Magnesium Stearate—designed to meet USP-NF/Ph. Eur./JP by grade, with IPEC-PQG GMP at go-live and a staged certification plan post-startup.
ABOUT NEXCIPIA
We are transforming the pharmaceutical excipient industry through innovative AI-powered manufacturing methods, delivering superior quality ingredients that enable smarter pharmaceutical formulations worldwide.
INNOVATION AT THE CORE
5 patents pending with 10 more in preparation, positioning us at the forefront of pharmaceutical excipient innovation.
AI-POWERED MANUFACTURING
Revolutionary AI methods ensure consistent quality, optimal efficiency, and reduced manufacturing costs across all product lines.
GLOBAL EXPANSION
Strategic manufacturing phases: Phase 1 in India, Phase 2 in USA, serving markets across India, USA, EU, Japan, and China.
"To revolutionize pharmaceutical manufacturing through intelligent excipients that enable safer, more effective, and accessible medications for patients worldwide."
Committed to advancing pharmaceutical science through innovation, quality, and global compliance standards.
PRODUCT PORTFOLIO
Pharmaceutical excipients with comprehensive grade specifications designed to meet USP-NF, Ph.Eur., and JP monograph requirements.
NEXCEL™
GRADE SPECIFICATIONS
| GRADE | PARTICLE SIZE D50 | MOISTURE CONTENT | PH RANGE | BULK DENSITY | TAP DENSITY | LOSS ON DRYING | PRIMARY APPLICATIONS |
|---|---|---|---|---|---|---|---|
| NEXCEL™ 101 | 50 μm | ≤ 5.0% | 5.5 - 7.5 | 0.28 - 0.35 g/mL | 0.40 - 0.60 g/mL | ≤ 5.0% | Direct compression, low-dose APIs |
| NEXCEL™ 102 | 90 μm | ≤ 5.0% | 5.5 - 7.5 | 0.32 - 0.38 g/mL | 0.50 - 0.65 g/mL | ≤ 5.0% | Direct compression, general purpose |
| NEXCEL™ 200 | 180 μm | ≤ 5.0% | 5.5 - 7.5 | 0.31 - 0.37 g/mL | 0.45 - 0.60 g/mL | ≤ 5.0% | Wet granulation, sustained release |
DIRECT COMPRESSION
Recommended for 5-85% w/w loading. Optimal at 50-200 MPa compression force.
WET GRANULATION
Superior binding at 15-25% w/w. Compatible with aqueous and non-aqueous systems.
REGULATORY COMPLIANCE
Meets all three major pharmacopoeial standards. ICH Q3D compliant.
AI-POWERED TECHNOLOGY
Revolutionizing pharmaceutical excipient manufacturing through cutting-edge artificial intelligence and machine learning technologies.
AI-Powered Quality Control
Machine learning algorithms continuously monitor and optimize production parameters to ensure consistent product quality and reduce batch variations.
Predictive Manufacturing
Advanced AI models predict optimal processing conditions, maintenance schedules, and yield optimization for maximum efficiency.
Smart Data Integration
Comprehensive data collection and analysis system integrating all manufacturing processes for intelligent decision-making.
Performance Analytics
Advanced analytics platform providing insights into production efficiency, quality trends, and predictive maintenance requirements.
Our patent-pending AI manufacturing system targets next-generation pharmaceutical excipient production technology.
SMART MANUFACTURING CAPABILITIES
Our AI-powered manufacturing system delivers unprecedented control and consistency across all production processes.
PROCESS OPTIMIZATION
AI continuously optimizes manufacturing parameters for maximum efficiency and quality.
REAL-TIME ADJUSTMENTS
Instant process modifications based on real-time quality monitoring and feedback.
QUALITY ASSURANCE
Automated quality control systems ensure consistent product specifications.
PRECISION CONTROL
Precise control of particle size, moisture content, and critical parameters.
MANUFACTURING
Strategic global manufacturing approach with ultra-modern, AI-enhanced facilities delivering world-class pharmaceutical excipients.
PHASE 1 - INDIA FACILITY
Planned state-of-the-art manufacturing facility in India utilizing advanced AI-powered production systems. Designed for high-volume production with uncompromised quality standards.
PHASE 2 - USA EXPANSION
Planned expansion to the United States market with a dedicated manufacturing facility to serve North American pharmaceutical companies with reduced lead times.
TARGET MARKETS
Strategic positioning to serve key pharmaceutical markets worldwide with localized manufacturing and distribution.
REGULATORY & QUALITY
Comprehensive quality management and regulatory compliance framework supporting global pharmaceutical excipient requirements through rigorous standards and documentation.
Standards & Compliance Framework
EXCIPIENT GMP STANDARDS
ISO MANAGEMENT SYSTEMS
Compendial Compliance & Safety
PHARMACOPOEIAL COMPLIANCE
SAFETY DECLARATIONS
Regulatory Documentation Pathways
US REGULATORY PATHWAY
EU REGULATORY PATHWAY
CONTACT
Get in touch with our technical team for product inquiries, custom specifications, or partnership opportunities.